More on PTGX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $140.32 |
|
|||
| Open | $140.08 | ||||
| 52 Wk High | $24.52 | ||||
| 52 Wk Low | $10.02 | ||||
| Day High | $142.37 | ||||
| Day Low | $137.91 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 865,926 | ||||
- Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: BlackRock, Inc.
- Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
- Protagonist Therapeutics (PTGX) PT Raised to $160 at TD Cowen
- U.S. biotech SMids: Q3 earnings preview
- UBS Starts Protagonist Therapeutics (PTGX) at Buy
- Form 4 Protagonist Therapeutics For: Sep 30 Filed by: Ali Asif
- Form 144 Protagonist Therapeutics Filed by: Ali Asif
- Form 4 Protagonist Therapeutics For: Sep 08 Filed by: PATEL DINESH V PH D
- Protagonist Therapeutics launches $300M share repurchase program
- Protagonist Therapeutics Announces $300 Million Share Repurchase Program
Entities mentioned with PTGX
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
